ESE welcomes Horizon Therapeutics as Corporate Supporter
We are delighted to welcome Horizon Therapeutics as Corporate Supporters of ESE. Horizon Therapeutics is a biopharmaceutical company focused on developing and commercialising innovative medicines. The company has a product portfolio that includes treatments for diseases such as gout, thyroid eye disease, or neuromyelitis optica spectrum disorder (NMOSD), and is actively involved in the development of new therapies for these and other conditions.
We are grateful for the ongoing support of all of our industry partners which enables us to deliver the comprehensive range of activities we currently offer. A list of all our Corporate Members and Supporters can be found here.